Literature DB >> 26731727

The importance of para-aortic lymph nodes in sentinel lymph node mapping for endometrial cancer by using hysteroscopic radio-isotope tracer injection combined with subserosal dye injection: Prospective study.

Fumio Kataoka1, Nobuyuki Susumu2, Wataru Yamagami2, Michiko Kuwahata2, Aya Takigawa2, Hiroyuki Nomura2, Hiroya Takeuchi3, Tadaki Nakahara4, Kaori Kameyama5, Daisuke Aoki2.   

Abstract

OBJECTIVE: The objective of this study is to evaluate the detection rate and diagnostic accuracy of sentinel lymph node (SN) mapping using hysteroscopic sub-endometrial injection of 99m-Technetium labeled phytate (Radio-isotope; RI method) and subserosal Indocyanine green (ICG) injection (Dye method) in patients with endometrial cancer.
METHODS: From April 2009 to December 2012, prospective evaluation of 57 Japanese endometrial cancer patients undergoing SN mapping using RI method combined with Dye method was done. To combine RI method or no was determined by a status of RI supply of the tracer injection day. As for 32 cases, both (RI+Dye) methods were used and 23 cases were performed only in Dye method. The primary endpoint was estimation of sensitivity and negative predictive value (NPV) of SN, and analysis of the distribution of SNs with metastasis.
RESULTS: At least one SN was detected in 100% and average number of detected SNs was 6.0 in RI+Dye method. Sensitivity and NPV were 100%, 100%, respectively. From results of SN mapping, 62.8% of SNs were present in pelvic and 37.1% in para-aortic lymph nodes (PAN). Total 56.3% of lymph nodes with metastasis were present in pelvic and 43.8% in PAN, and the distribution has no difference with SN mapping results (P=0.602). Among 13 cases with metastatic SNs, 76.9% cases showed metastasis in PAN.
CONCLUSIONS: This SN mapping procedure for endometrial cancer patients revealed high detection rate, sensitivity, NPV, and also indicated the importance of the SN exploration in PAN area.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endometrial cancer; Hysteroscopic; Para-aortic lymph node; Sentinel lymph node

Mesh:

Substances:

Year:  2015        PMID: 26731727     DOI: 10.1016/j.ygyno.2015.12.023

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  9 in total

1.  ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.

Authors:  Nicole Concin; Carien L Creutzberg; Ignace Vergote; David Cibula; Mansoor Raza Mirza; Simone Marnitz; Jonathan A Ledermann; Tjalling Bosse; Cyrus Chargari; Anna Fagotti; Christina Fotopoulou; Antonio González-Martín; Sigurd F Lax; Domenica Lorusso; Christian Marth; Philippe Morice; Remi A Nout; Dearbhaile E O'Donnell; Denis Querleu; Maria Rosaria Raspollini; Jalid Sehouli; Alina E Sturdza; Alexandra Taylor; Anneke M Westermann; Pauline Wimberger; Nicoletta Colombo; François Planchamp; Xavier Matias-Guiu
Journal:  Virchows Arch       Date:  2021-02       Impact factor: 4.064

2.  Survey of the clinical practice pattern of using sentinel lymph node biopsy in patients with gynecological cancers in Japan: the Japan Society of Gynecologic Oncology study.

Authors:  Shinichi Togami; Hiroaki Kobayashi; Hitoshi Niikura; Muneaki Shimada; Nobuyuki Susumu; Tomohito Tanaka; Yoshito Terai; Tomoyuki Nagai; Tsukasa Baba; Hideaki Yahata; Wataru Yamagami; Ken Yamaguchi; Tsuyoshi Yamashita; Nobuo Yaegashi; Hidetaka Katabuchi; Daisuke Aoki
Journal:  Int J Clin Oncol       Date:  2021-03-25       Impact factor: 3.402

Review 3.  Contributions of the Japanese Gynecologic Oncology Group (JGOG) in Improving the Quality of Life in Women With Gynecological Malignancies.

Authors:  Masayuki Futagami; Yoshihito Yokoyama; Muneaki Shimada; Shinya Sato; Etsuko Miyagi; Akiko Tozawa-Ono; Nao Suzuki; Masaki Fujimura; Yoichi Aoki; Satoru Sagae; Toru Sugiyama
Journal:  Curr Oncol Rep       Date:  2017-04       Impact factor: 5.075

4.  Serum miRNA-204-5p as a potential non-invasive biomarker for the diagnosis of endometrial cancer with sentinel lymph node mapping.

Authors:  Cailiang Wu; Xuexin Zhou; Jiayong Li; Ruiying Xiao; Haomin Xin; Lei Dai; Yaping Zhu; Wei Bao
Journal:  Oncol Lett       Date:  2022-06-07       Impact factor: 3.111

Review 5.  Towards an Optical Biopsy during Visceral Surgical Interventions.

Authors:  David Benjamin Ellebrecht; Sarah Latus; Alexander Schlaefer; Tobias Keck; Nils Gessert
Journal:  Visc Med       Date:  2020-03-05

6.  Paraaortic sentinel lymph node detection in intermediate and high-risk endometrial cancer by transvaginal ultrasound-guided myometrial injection of radiotracer (TUMIR).

Authors:  Martina Aida Angeles; Federico Migliorelli; Sergi Vidal-Sicart; Adela Saco; Jaume Ordi; Cristina Ros; Pere Fusté; Meritxell Munmany; Sílvia Escura; Núria Carreras; Nuria Sánchez-Izquierdo; Jaume Pahisa; Aureli Torné; Pilar Paredes; Marta Del Pino
Journal:  J Gynecol Oncol       Date:  2021-03-20       Impact factor: 4.401

7.  Sentinel node mapping for post-endoscopic resection gastric cancer: multicenter retrospective cohort study in Japan.

Authors:  Shuhei Mayanagi; Naoto Takahashi; Norio Mitsumori; Takaaki Arigami; Shoji Natsugoe; Yoshihisa Yaguchi; Takeshi Suda; Shinichi Kinami; Masaki Ohi; Hirofumi Kawakubo; Yasunori Sato; Hiroya Takeuchi; Takashi Aikou; Yuko Kitagawa
Journal:  Gastric Cancer       Date:  2020-01-11       Impact factor: 7.370

8.  Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.

Authors:  Hans Nagar; Nina Wietek; Richard J Goodall; Will Hughes; Mia Schmidt-Hansen; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2021-06-09

Review 9.  Current landscape and future perspective of sentinel node mapping in endometrial cancer.

Authors:  Giorgio Bogani; Francesco Raspagliesi; Umberto Leone Roberti Maggiore; Andrea Mariani
Journal:  J Gynecol Oncol       Date:  2018-11       Impact factor: 4.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.